Drugs that contain Diroximel Fumarate

1. List of Vumerity drug patents

VUMERITY's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10080733 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases
Sep, 2033

(10 years from now)

US8669281 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases
Sep, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9090558 BIOGEN INC Prodrugs of fumarates and their use in treating various diseases
Sep, 2033

(10 years from now)

Market Authorisation Date: 29 October, 2019

Treatment: Method of treating multiple sclerosis

Dosage: CAPSULE, DELAYED RELEASE;ORAL

How can I launch a generic of VUMERITY before it's patent expiration?
More Information on Dosage

VUMERITY family patents

18

United States

4

Singapore

4

New Zealand

3

Australia

3

Canada

2

Israel

2

Lithuania

2

Hungary

2

Korea, Republic of

2

China

2

Japan

EA

2

EA

2

European Union

1

Denmark

1

Mexico

1

Hong Kong

1

Slovenia

1

Brazil

1

Croatia

1

Portugal

1

Cyprus

1

Spain

1

Poland

1

RS

1

Ukraine

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in